Provides Patent Protection in Europe Through at Least December 2040 Further IP Protection for TNX-103 (Oral Levosimendan) and Other Drug…
AI-first platform transforms recruitment delays into instant enrollments by matching, engaging and enrolling patients in clinical trials.KANSAS CITY, Mo.--(BUSINESS WIRE)--Trially®,…
Preliminary analysis showed the 2025-2026 formula of Spikevax generated greater than an 8-fold increase in LP.8.1-neutralizing antibodies across age groupsClinical…
BOSTON and NASHVILLE, Tenn. and NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Drug Hunter, the trusted knowledge platform for drug…
OMAHA, Neb.--(BUSINESS WIRE)--Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today…
OMAHA, Neb.--(BUSINESS WIRE)--Lindsay Corporation (NYSE: LNN), a leading global manufacturer and distributor of irrigation and infrastructure equipment and technology, today…
Clinically validated ADHD diagnostic model positions Mentavi as a benchmark for trustworthy digital health solutions. GRAND RAPIDS, MICHIGAN / ACCESS…
DORADO, PUERTO RICO / ACCESS Newswire / September 15, 2025 / Pharma-Bio Serv, Inc. ("Pharma-Bio Serv" or the "Company") (OTCQB:PBSV),…
This release contains a headline correction from the previous publication.Positive start to FY 2026 with steady revenue, data growth and…
Positive start to FY 2026 with steady revenue, data growth and new leadership HACKENSACK, NJ / ACCESS Newswire / September…